Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -497.79x is 82% above its 4-year average of -2715.99x, near the high end of its 4-year range (-15171.00x–44.02x).
211.64% below its 12-month average of -159.73x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -15.91x.
INTEREST COVERAGE RATIO
-497.79x
INTEREST COVERAGE RATIO AVG TTM
-159.73x
INTEREST COVERAGE RATIO AVG 3Y
-506.67x
INTEREST COVERAGE RATIO AVG 5Y
-2715.99x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-211.64%
CURRENT VS 3Y AVG
+1.75%
CURRENT VS 5Y AVG
+81.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 330 covered companies
CURRENT VS SECTOR MEDIAN
-11723.99%
vs the sector median at left
Castle Biosciences, Inc.
Market Cap
$1.12B
Interest Coverage Ratio
-497.79x
TTM Avg
-159.73x
3Y Avg
-506.67x
5Y Avg
-2715.99x
Market Cap
$1.12B
Interest Coverage Ratio
5.51x
TTM Avg
6.14x
3Y Avg
19.44x
5Y Avg
31.00x
Market Cap
$1.11B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Interest Coverage Ratio
1.60x
TTM Avg
1.00x
3Y Avg
0.57x
5Y Avg
0.46x
Market Cap
$1.16B
Interest Coverage Ratio
2.05x
TTM Avg
1.65x
3Y Avg
1.11x
5Y Avg
0.98x
Market Cap
$1.05B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Interest Coverage Ratio
-192.41x
TTM Avg
28.86x
3Y Avg
28.86x
5Y Avg
28.86x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.12B | -497.79x | -159.73x | -506.67x | -2715.99x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 5.51x | 6.14x | 19.44x | 31.00x |
| IRadimed Corporation (IRMD)vs › | $1.11B | N/A | N/A | N/A | N/A |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.15B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.60x | 1.00x | 0.57x | 0.46x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 2.05x | 1.65x | 1.11x | 0.98x |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.34x | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.04B | -192.41x | 28.86x | 28.86x | 28.86x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 0.79x | 0.59x | 2.04x | 2.37x |
Interest Coverage
-497.8x
Debt/Equity
0.08
Current Ratio
6.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -15.91x |
| 2026-03-31 | -137.37x |
| 2025-12-31 | -159.46x |
| 2025-09-30 | -283.50x |
| 2025-06-30 | -202.43x |
| 2025-03-31 | -1642.82x |
| 2024-12-31 | 44.02x |
| 2024-09-30 | 25.27x |
| 2024-06-30 | 18.56x |
| 2024-03-31 | -390.79x |
| 2023-12-31 | -2829.00x |
| 2023-09-30 | -4820.00x |
| 2023-06-30 | -7052.33x |
| 2023-03-31 | -7880.50x |
| 2022-12-31 | -5708.00x |
| 2022-09-30 | -3589.33x |
| 2022-06-30 | -6092.25x |
| 2022-03-31 | -8172.00x |
| 2021-12-31 | -15171.00x |
| 2020-12-31 | -7.68x |
| 2020-09-30 | -5.53x |
| 2020-06-30 | -0.84x |
| 2020-03-31 | 1.36x |
| 2019-12-31 | 3.41x |
| 2019-09-30 | 4.07x |
| 2019-06-30 | 0.36x |
| 2019-03-31 | -0.31x |
| 2018-12-31 | 7.33x |
| 2018-09-30 | -5.01x |
| 2018-06-30 | -5.08x |
| 2018-03-31 | -5.82x |
